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Purpose: Stenting has been developed to deal with airway stenosis and is applicable 
in patients with post-intubation tracheal stenosis (PITS) in whom surgery would not 
be indicated. The purpose of this study was to investigate the prognostic factors in 
inoperable patients in whom a silicone stent was inserted due to PITS. Materials 
and Methods: We retrospectively evaluated 55 PITS patients undergoing silicone 
stenting between January 2001 and December 2009. Results: Silicone stent was in-
serted to narrowed trachea after the combination of pre-dilatation including laser 
cauterization, mechanical bougienation and ballooning. Following airway stabiliza-
tion, the stent could be removed successfully in 40% (22/55) of the patients after   
median 12 months of stenting. However, in 60% (33/55) of patients, the stent could 
not be removed successfully and surgical management was needed after initial stabi-
lization. Multivariate analysis revealed that the stent could be successfully removed 
more frequently in those who do not have cardiovascular disease [odds ratio 
(OR)=12.195; p=0.036] and the intervention was performed within 6 months after 
intubation (OR=13.029; p=0.031). Conclusion: Among those patients undergoing 
silicone stenting due to PITS, the stent could be successfully removed when patients 
do not have cardiovascular disease and stented within 6 months after intubation.
Key Words:    Intervention, post-intubation tracheal stenosis, prognosis, rigid bron-
choscopy, silicone stent
INTRODUCTION
Tracheal stenosis (narrowing of the trachea) is a life-threatening, emergent disease 
with an increasing frequency.1,2 One of the most common etiologies of benign tra-
cheal stenosis is post-procedural tracheal stenosis, such as that following long-
term tracheal intubation or following tracheostomy. Although the use of low pres-
sure cuffs has reduced the incidence of post-intubation tracheal stenosis (PITS) by 
10-fold, the occurrence of PITS has increased, due to early application of tracheos-
tomy in the intensive care unit.2,3
The management of PITS is a complex problem that requires a multi-disci-
plined approach. Generally, the preferred management is open resection and re-So Yeon Lim, et al.
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posed for subglottic stenosis, although it has been used with 
other airway site assessment. It was defined as follows: 
Grade I: ≤50% lumen stenosis; Grade II: 51-70% lumen 
stenosis; Grade III: 71-99% lumen stenosis; Grade IV: no 
lumen.4 “Successful group” was defined as the group of the 
stent being removed successfully (usually after 6-12 
months) without re-insertion or tracheostomy during the 
follow-up. “Unsuccessful group” was defined when the 
stent removal was intolerable and following re-stenting or 
surgical intervention was needed. 
Stents
A Natural (M1S Co., Seoul, Korea) stent of 12-14 mm out-
er diameter was used for tracheal stenosis (Fig. 1). A new 
silicone stent, named the Natural stent, was developed by 
the TNO Company in 2001. This stent is composed of 
molded silicone and is straight in shape.3,5 It features regu-
larly placed ‘C’ circular ribs on its outer surface.3,5 These 
stent designs increase stent-to-wall contact due to ‘C’ shaped 
studs, and have a theoretical advantage to reduce the stent 
migration and granulation tissue overgrowth.3,5 An adequate 
size and type of stent were selected and used according to 
the interventionist’s decision.
Airway intervention techniques and follow-up
Airway intervention was performed following standard tech-
niques, as described by Dumon.6,7 Briefly, under general an-
esthesia, patients were intubated with a rigid bronchoscope 
tube (Hopkins, Karl-Storz, Germany), and a flexible bron-
choscope (EVIS BF 1T240, Olympus, Tokyo, Japan) was 
introduced through this rigid bronchoscope tube and airway 
narrowing was examined. The length of stenotic lesion was 
measured by a scale mark of flexible bronchoscope and a 
stent of appropriate size (1 cm longer than the stenotic 
length) was selected by the interventionist. Patients under-
went mechanical dilatation prior to stenting, such as dilata-
tion with rigid tubes, ballooning (Boston Scientific, Boston, 
MA, USA), and laser cauterization (LaserSonics, Mipiltas, 
CA, USA). A stent of an appropriate size was folded longi-
tudinally, introduced into a stent pusher (BryanCorp., Wo-
burn, MA, USA), and re-positioned using alligator forceps.
Patients were discharged from hospital one to three days 
following the procedure. We assessed the symptomatic re-
lief as interviewing the patients in the next morning of the 
bronchoscopic intervention. Patients were followed at 1, 3, 6, 
9 and 12 months after intervention with chest radiography 
and spirometry, and three-dimensional CT and flexible 
anastomosis.2 However, stenting is recommended in pa-
tients with PITS in whom surgery is not indicated due to 
poor general condition or long involvement of the trachea.2,3 
There is an increasing need to investigate the factors that fa-
vor stenting in the management of patients with PITS, be-
cause the stent can successfully be removed in only 30-40% 
of stented patients. Therefore, we investigated such prognos-
tic factors in initially inoperable patients in whom stenting 
was performed.
MATERIALS AND METHODS
　　　
Patients
Among 59 patients who underwent bronchoscopic silicone 
stenting for the treatment of initially inoperable PITS at the 
Samsung Medical Center, Seoul, Korea between January 
2001 and December 2009, 4 patients lost follow-up within 
3 months, and 55 patients who had complex type stenotic 
lesion were included in this study. Twenty-two patients 
were had already been studied in the prior study by Park, et 
al.3 Bronchoscopic intervention in patients with PITS was 
indicated when all of the following conditions were met: 1) 
The degree of dyspnea was greater than American Thoracic 
Society grade 3; 2) obstruction in tracheal lumen exceeded 
25%; 3) general condition was tolerable for intervention, 
and 4) distal airways were patent.
The Institutional Review Board of the Samsung Medical 
Center approved this study. Written informed consent was 
obtained from each patient.
Definitions 
The Myer-Cotton stenosis grading system was initially pro-
Fig. 1. A natural silicone stent.Prognostic Factor for PITS Stenting
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intervention was conducted in 48 patients, and 7 patients 
underwent stenting at second intervention after first me-
chanical dilatation. Their median age was 60 years (range, 
16-84), and 22 patients (40%) were males (Table 1). The 
intubation-to-intervention time was median 4 months 
(range, 0.5-480 months). The causes of the tracheal stenosis 
were post-intubation (72.7%) and post-tracheostomy 
(27.3%). Baseline spirometry data were available for 20 pa-
tients (36.4%); the forced expiratory volume in 1 s (FEV1), 
forced vital capacity (FVC), and FEV1/FVC were 61% (18-
113%), 68% (22-123%), and 64% (23-89%), respectively.
Bronchoscopic findings and interventions
Bronchoscopic findings and interventions are summarized 
in Table 2. The luminal narrowing was classified by the 
Myer and Cotton grading system.4 Grade I was observed in 
5 patients (9.1%), grade II was evident in 26 patients 
(47.3%), grade III in 17 patients (30.9%), and grade IV in 7 
patients (12.7%). 
Outcomes and complications
The overall clinical outcomes are shown in Fig. 2. Success-
bronchoscopy were performed before stent removal. Stent 
removal was planned 12 months after the intervention when 
the patients were stable and airway related problem did not 
develop at least for 6 months.
Statistical analysis
For statistical analysis, PAWS 17.0 (SPSS Inc., Chicago, IL, 
USA) was used. Group comparisons of categorical variables 
were made using the Pearson chi-square test or Fisher’s ex-
act test. To assess the relationship between continuous vari-
ables, the Mann-Whitney U test was used. Multivariate lo-
gistic regression analysis was used to determine indepen-
dent predictors of failure to attain a stent-free airway. Among 
the variables used in this model, predictive factors with a p-
value less than 0.15 were selected for multivariate logistic 
regression analysis. A two-tailed p-value <0.05 was consid-
ered statistically significant. 
 
RESULTS
 
Clinical characteristics of patients
Total 55 patients were included. The stent insertion at first 
Table 1. Baseline Characteristics of the Study Population (n=55)
Variable Number (% or range)
Age (yrs) 60 (16-84)
Gender (male) 22 (40)
Cause of intubation
    Medical       
        Respiratory failure 20 (36.4)
        Cardiac failure   7 (12.7)
        Neurological problem   8 (14.5)
        Burn   1 (1.8)
        Drug intoxication   5 (9.1)
    Surgical 
        Operation    5 (9.1)
        Trauma   8 (14.5)
        Suicide   1 (1.8)
Cause of tracheal stenosis
    Post-intubation 40 (72.7)
    Post-tracheostomy 15 (27.3)
Intubation-to-intervention time, months   4 (0.5-480)
Tracheostomized state at the first visit 20 (36.3)
Baseline spirometer data (n=20)
    FEV1 (% predicted) 61 (18-113)
    FVC (% predicted) 68 (22-123)
    FEV1/FVC (% predicted) 64 (23-89)
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
Data are presented as n (%) or median (range).
Table 2. Bronchoscopic Findings and Parameters of Inter-
vention (n=55)
Variable Number 
(% or range)
Stenosis site, overlapped (n=67)
    Subglottis   9 (16.4)
    Upper trachea 39 (70.9)
    Mid-trachea 13 (23.6)
    Lower trachea   6 (10.9)
Stenosis type
    Fibrous stricture 50 (90.9)
    Malacia   1 (1.8)
    Fibrous stricture+malacia   4 (7.3)
Characteristics of the lesion at first bronchoscopy
    Myer and Cotton Grade 
        I   5 (9.1)
        II 26 (47.3)
        III 17 (30.9)
        IV   7 (12.7)
Luminal diameter before procedure, mm   5 (0-10)
Luminal diameter after procedure, mm 12 (9-14)
Length of stent, mm 50 (30-85)
Method of airway dilatation (overlapped)
    Ballooning   7 (12.7)
    Nd-YAG laser 13 (23.6)
    Bougienation 50 (90.9)
Nd-YAG, neodymium-yttrium aluminum garnet. 
Data are presented as n (%) or median (range).So Yeon Lim, et al.
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the variables used in the model, no cardiovascular disease 
(OR=12.195; p=0.036; 95% CI=1.179-125.012) and initia-
tion of treatment within 6 months (13.029; 0.031; 1.257-
135.082) were independently associated with successful stent 
removal (Table 4).
DISCUSSION
The treatment of initially inoperable PITS requires a multi-
disciplinary approach, including initial conservative treat-
ment, interventional bronchoscopy, and surgical manage-
ment such as tracheal resection and end to end anastomosis, 
slide tracheoplasty, and open expansion tracheoplasty with 
stent fixation, especially for long segment tracheal steno-
sis.8 Surgical resection and re-anastomosis have been the 
first choice of treatment when the patients’ condition is tol-
erable, and interventional bronchoscopy has been applied if 
the general condition is impossible for an operation.9 How-
ever, even with developments in the management of criti-
cally ill patients, surgical treatment is still not indicated in 
PITS patients with poor neurological, cardiovascular, or re-
spiratory condition.10 In these patients, interventional bron-
choscopy is a good alternative and has led to satisfactory 
ful stent removal occurred in 22 patients (40%), and dura-
tion of stent placement was median 12 months (Fig. 3). 
However, re-stenosis was done in 33 patients (60%). 
Among them, persistent stent placement occurred in 23 pa-
tients (41.8%). Surgical management, such as tracheal re-
section with end-to-end anastomosis, occurred in 10 pa-
tients (18.2%).
Pneumothorax occurred in one patient. Late complications 
including stent migration (36.4%), mucostasis (21.8%), and 
granulation tissues formation at the end of the stent (49.1%) 
were observed, and repeated bronchoscopic interventions 
were required to treat these complications.
 
Comparison of the “successful group” and 
“unsuccessful group”
Patients were grouped according to whether the stent could 
be successfully removed (successful group) or whether the 
stent remained or received surgical intervention (unsuccess-
ful group) (Table 3). The patients of unsuccessful group had 
cardiovascular disease (p=0.008), neurological sequelae 
(p=0.018), high Myer and Cotton grade (p=0.075), and the 
delay of treatment more than 6 months (p=0.005). Multivari-
ate logistic regression model was used to determine indepen-
dent predictors of the successful removal of the stent. Among 
Fig. 2. Outcomes of bronchoscopic interventions in 59 post-intubation tracheal stenosis patients. 
Fig. 3. A representative case of temporary stenting for post-intubation tracheal stenosis. (A) Marked narrowing of the trachea was noted in a 59-year-old 
male patient after neurosurgical operation. (B) After silicone stent was inserted, the trachea was widened. (C) The stent was removed 1 year after the inter-
vention. The widened diameter of trachea was maintained successfully.
A B C
Post-intubation tracheal stenosis with stenting (n=59)
Follow-up loss within 3 months (n=4)
Stable (n=22) Re-stenosis (n=33)
Stent removal (n=55)Prognostic Factor for PITS Stenting
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tion tracheal stenosis and was performed in one of the largest 
centers for interventional bronchoscopy in Asia. We demon-
strated that the factors contributing to successful stent remov-
al included no history of cardiovascular disease and initiation 
of treatment within 6 months after intubation. To our best 
results in selected patients with benign airway stenosis. A 
positive outcome of interventional bronchoscopy was re-
ported in 32 PITS patients by Park, et al.3
The current study was conducted to reveal prognostic fac-
tors for tracheal stenting in initially inoperable post-intuba-
Table 3. Subgroup Analysis between “Successful group” (Stable after Removal) and “Unsuccessful group” (Restented or 
Operated Patients)
Variables Successful group (% or range) 
(n=22)
Unsuccessful group (% or range) 
(n=33) p value
Age, yrs (range)      60 (24-84)   61 (16-80) 0.286
Gender, male      9 (40.9) 13 (39.4) 1.000
Cardiovascular disease    1 (4.5) 12 (36.4) 0.008
Neurologic sequelae    1 (4.5) 11 (33.3) 0.018
Presence of tracheostomy      5 (22.7) 11 (33.3) 0.547
FEV1, predicted %
    Before stenting (n=17)      67 (18-84)     47 (20-113) 0.753
    After stenting (n=39)     92.5 (40-126)     89 (22-124) 0.364
    After removal of stent (n=14)     92.5 (38-127) - -
        Change after removal of stent    26 (1-44) - -
Stenotic site 1.000
    Subglottis 2 (9)   7 (21.2)
    Upper trachea     15 (68.2) 24 (72.7)
    Mid trachea      5 (22.7)   9 (27.3)
    Lower trachea 2 (9)   4 (12.1)
Characteristics of the lesion at first bronchoscopy
    Myer and Cotton Grade  0.075
        I      3 (13.6) 2 (6.1)
        II    14 (63.6) 12 (36.4)
        III    3 (9.1) 14 (42.4)
        IV    2 (9.1)   5 (15.2)
Luminal diameter before procedure, mm    5 (0-6)   4 (0-10) 0.609
Luminal diameter after procedure, mm    12 (9-14) 12 (9-14) 0.536
Stenosis type
    Fibrous stricture    21 (95.5) 30 (90.9) 1.000
    Fibrous stricture and malacia    1 (4.5) 3 (9.1) 0.522
Length of the stent    4.5 (3.5-6)    5 (3-8.5) 0.145
Stenosis-to-intervention time      3 (1-10)   5 (1-60) 0.110
     Intervention within 6 months   20 (90.9) 20 (60.6) 0.005
Visit of emergency room 13 (59) 21 (63.6) 0.570
Emergent bronchoscopy    10 (45.5) 16 (48.5) 0.782
Duration of follow-up                   13 (6-156) 20 (7-97) 0.918
FEV1, forced expiratory volume in 1 second.
Data are presented as n (%) or median (range).
Table 4. Multivariate Logistic Regression Analysis for Determining the Factors of Successful Stent Removal
Variables Odds ratio 95% confidence intervals p value
Neurologic sequelae   0.197 0.017-2.306 0.196
Cardiovascular disease  12.195     1.179-125.012 0.036
Myer and Cotton Grade   0.513 0.181-1.455 0.210
Length of stent   0.684 0.239-1.954 0.478
Intervention within 6 months after intubation 13.029     1.257-135.082 0.031So Yeon Lim, et al.
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other undisclosed factors, which should be revealed by future 
studies. Second, in majority of patients (35 patients, 64%), 
spirometer data were missing due to patients’ condition. Oth-
er objective measurements should be sought in future study.
In conclusion, among patients undergoing silicone stent-
ing due to initially inoperable PITS, the stent could be suc-
cessfully removed when the patients did not have cardiovas-
cular disease and stented less than 6 months after intubation.
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knowledge, this is the first reported study on the prognosis of 
PITS, managed by bronchoscopic intervention with silicone 
stenting. In this study, the silicone stent could be successfully 
removed in 40% of patients. In 60% of patients, the stent 
could not be removed and they received surgical manage-
ment, demonstrating that the stent can be removed success-
fully only in a limited number of patients. The poor progno-
sis reflects not only the need for advances in bronchoscopic 
intervention, but also the shortage in the pathophysiological 
understanding and early diagnosis of PITS.
In this study, cardiovascular disease had a relevance to un-
favorable prognosis. For good prognosis, stent should pro-
mote healing of de-epithelialization of the stenotic lesions 
by allowing mucosal to grow and should not impede airway 
mucocilliary clearance, resisting bacterial contamination and 
avoiding excessive pressure that would impede capillary cir-
culation.11 However, cardiovascular disease may cause de-
fect of good blood supply to the mucosa of trachea. Also, 
symptomatic dyspnea might be increased when the patients 
had underlying cardiovascular disease. In addition, many 
co-morbidities and sequelae result in a poor general condi-
tion. These problems may lead to difficulties in both cough-
ing and stent-related complications such as mucostasis. 
Another important prognostic factor of successful stent 
removal in this study was the initiation of intervention with-
in 6 months after intubation. In the early phase, PITS is ini-
tiated by mucosal ulceration and perichondritis, followed 
by granulation tissue formation.12-14 In the later phase, carti-
laginous tracheal rings are damaged and resorbed, leading 
to the circumferential loss of mechanical support coupled 
with scar contracture, resulting in the collapse of the whole 
tracheal segment.15 Because stents provide resistance to 
scar contracture and provide support in areas of structural 
weakness because of cartilage loss, this severe stenosis is 
often indicated to surgical intervention.11 Thus, a favorable 
outcome would be predicted when the patients were re-
ferred prior to damage in the airway cartilages. Consistent 
with this, we found in the present study that it was an unfa-
vorable factor for the successful stent removal, when the 
initiation of treatment exceeds 6 months.
There are clear limitations in this study. It is a retrospective 
review of small sample size, which needs a large scaled pro-
spective study to avoid the lack of statistical significance in 
some potentially important confounders. Therefore, the deci-
sion to remove a stent will be made by considering the prog-
nostic factors being discussed in this study (no cardiovascu-
lar disease and initiation of treatment within 6 months) and 